更正：Shoushtari等人。转移性葡萄膜黑色素瘤患者中PKC抑制剂Sotrastaurin和PI3Kα抑制剂Alpelisib的Ib期研究巨蟹座：2021,13,5504。

IF 4.4 2区医学 Q1 ONCOLOGY

Cancers Pub Date : 2025-09-16 DOI:10.3390/cancers17183018

Alexander N Shoushtari, Shaheer Khan, Kimberly Komatsubara, Lynn Feun, Nicolas Acquavella, Shahnaz Singh-Kandah, Tiffany Negri, Alexandra Nesson, Kelly Abbate, Serge Cremers, Elgilda Musi, Grazia Ambrosini, Shing Lee, Gary K Schwartz, Richard D Carvajal

引用次数: 0

摘要

图[…]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Correction: Shoushtari et al. A Phase Ib Study of Sotrastaurin, a PKC Inhibitor, and Alpelisib, a PI3Kα Inhibitor, in Patients with Metastatic Uveal Melanoma. <i>Cancers</i> 2021, <i>13</i>, 5504.

查看原文本刊更多论文

Correction: Shoushtari et al. A Phase Ib Study of Sotrastaurin, a PKC Inhibitor, and Alpelisib, a PI3Kα Inhibitor, in Patients with Metastatic Uveal Melanoma. Cancers 2021, 13, 5504.

Figure [...].

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Cancers Medicine-Oncology

CiteScore

8.00

自引率

9.60%

发文量

5371

审稿时长

18.07 days

期刊介绍： Cancers (ISSN 2072-6694) is an international, peer-reviewed open access journal on oncology. It publishes reviews, regular research papers and short communications. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced.